# RYBREVANT
> **BLA761210** · Biologics License Application · Sponsor: JANSSEN BIOTECH · Approved 2021-05-21
## Drug
- **FDA Application Number:** BLA761210
- **Application type:** Biologics License Application
- **Brand name:** RYBREVANT
- **Generic name:** AMIVANTAMAB-VMJW
- **Active ingredients:** AMIVANTAMAB-VMJW
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** JANSSEN BIOTECH
- **Manufacturer:** Janssen Biotech, Inc.
- **First approval:** 2021-05-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761210)
---
*MORVS · CC0 1.0*